Genexine - Crunchbase Company Profile & Funding

Q: Where is Genexine's headquarters?

Genexine is located in Seongnam, Kyonggi-do, South Korea.

Q: Who invested in Genexine?

Genexine has 2 investors including IMM Private Equity And Hyundai Venture Investment Corporation.

Q: When was the last funding round for Genexine?

Genexine closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Genexine

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Genexine

CB Rank

389437

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.

Founded

obfuscation

Private

Venture - Series Unknown

Seongnam, Kyonggi-do, South Korea

51-100

www.genexine.com/

Biotechnology

Health Care

Life Science

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Details

Also Known As

Genexine Co., 제넥신

Operating Status

Active

Number of Exits

obfuscation

Company Type

For Profit

About the Company

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics. Our goal is to bring to patients medicines that will transform their lives.

Phone Number

+82316283200

Contact Email

recruit@genexine.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

GX-I7 (Efineptakin alfa)

A recombinant human interleukin-7 fused to hyFc that amplifies T-cell numbers to enhance immune response, used alone or with other cancer therapies.

GX-E4

A long-acting erythropoietin-based biologic for treating anemia, currently in phase 3 clinical trials.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genexine	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
IMM Private Equity	—	Venture Round - Genexine	—
IMM Private Equity	—	Venture Round - Genexine	—
IMM Private Equity	—	Venture Round - Genexine	—
IMM Private Equity	—	Venture Round - Genexine	—
IMM Private Equity	—	Venture Round - Genexine	—

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation
obfuscated obfuscation	Y-Biologics	—	Venture Round - Y-Biologics	obfuscated obfuscation